Drug Trial Radar · NCT03788863
A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or in the Roof of the Mouth (Cleft Palate) in Newborns and the Use of Glucocorticoids by the Mother During Pregnancy: a Meta-analysis
Last checked: Nov 19, 2026Latest source record: Apr 1, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
99,999
Actual
Start
Nov 16, 2018
Primary completion
Nov 29, 2018
Study completion Nov 29, 2018
Sponsor
- Lead sponsor
- LEO PharmaIndustry
- Sponsor type
- Industry
- Collaborators
- Bayer
- First posted
- Dec 28, 2018
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- Female only
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Glucocorticoids are drugs that have many effects on body metabolism, raise sugar level in the blood, and reduce inflammation. By applying a statistical technique for combining the findings from a systematic literature review (meta analysis), researchers want to learn more about the relationship of the risk to develop a separation in the roof of the mouth (cleft palate) in newborns and contact with glucocorticoids during pregnancy.
Conditions
- Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development
Interventions
Diflucortolone valerate (BAY866146)Drug
Follow clinical administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of any type of orofacial cleftTime frame: Retrospective analysis from 1-Jan-1997 to 25-Jun-2018
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Many locations
Multiple Locations, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.